Sphera Funds Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-134,414
| Closed | -$5.29M | – | 105 |
|
|
2023
Q2 | $5.29M | Sell |
134,414
-97,177
| -42% | -$3.43M | 0.83% | 48 |
|
|
2023
Q1 | $5.63M | Buy |
231,591
+36,000
| +18% | +$788K | 0.94% | 37 |
|
|
2022
Q4 | $4.19M | Sell |
195,591
-386,238
| -66% | -$8.24M | 0.9% | 33 |
|
|
2022
Q3 | $10.4M | Sell |
581,829
-380,641
| -40% | -$5M | 1.45% | 18 |
|
|
2022
Q2 | $9.26M | Buy |
962,470
+188,340
| +24% | +$2.36M | 0.99% | 22 |
|
|
2022
Q1 | $13M | Buy |
774,130
+289,129
| +60% | +$4.27M | 1.84% | 16 |
|
|
2021
Q4 | $8.11M | Hold |
485,001
| – | – | 0.89% | 37 |
|
|
2021
Q3 | $7.88M | Sell |
485,001
-14,999
| -3% | -$163K | 0.66% | 49 |
|
|
2021
Q2 | $3.15M | Buy |
+500,000
| New | +$3.23M | 0.21% | 88 |
|
|
2020
Q3 | – | Sell |
-200,000
| Closed | -$1.02M | – | 121 |
|
|
2020
Q2 | $1.02M | Buy |
200,000
+76,576
| +62% | +$319K | 0.1% | 80 |
|
|
2020
Q1 | $425K | Sell |
123,424
-744,776
| -86% | -$4.35M | 0.05% | 70 |
|
|
2019
Q4 | $7.45M | Buy |
+868,200
| New | +$3.1M | 0.61% | 35 |
|
Sphera Funds Management's ISEE Position: Q3 2023 in Review
Sphera Funds Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 134,414 shares — an estimated $5.29M sold.
Sphera Funds Management first reported a position in ISEE in Q4 2019 and held it in 12 quarters. The position peaked at $13M in Q1 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Sphera Funds Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Sphera Funds Management sold 134,414 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $5.29M.
- Sphera Funds Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
- Sphera Funds Management's IVERIC bio, Inc. Common Stock position peaked at $13M in Q1 2022.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Sphera Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.